The Ebola epidemic, which tore through West Africa in 2014, continues to pose a huge global health challenge. It has prompted unparalleled collaboration between academia, industry and government. This has led to the generation and trialing of new vaccine candidates at unprecedented rates.
This is certain to be an informative and enthralling discussion about how entrepreneurs, academics, industry professionals and governments can learn lessons from the collaborative approach used to fight Ebola, and how this can lead to revolutionary new approaches in drug discovery and development.
After the event there will be an opportunity to engage with the high-profile speakers and sponsors, in a less formal setting.
Don't miss this opportunity to join more than 200 scientist and entrepreneurs for this major event. Attendance is free to all but prior registration is required via http://www.oxfordbiotech.org/event-ebola/